Trident Lifeline Share Price

    BSE
    267
    -2.25 (0.75%)
    TLL • 14 Jul, 2025 | 03:29 PM
    BUY
    The current prices are delayed, login or Open Demat Account for live prices.

    Trident Lifeline Stock Performance

    1W Return0.68
    1Y Return-11.00
    Today's Low265
    Prev. Close269.25
    Mkt Cap (Cr.)307.03
    1M Return-1.09
    3Y Return0.00
    52-Week High339
    Open266.50
    PE Ratio23.52
    6M Return0.38
    Today's High267.15
    52-Week Low222
    Face Value10

    Trident Lifeline Company background

    Founded in: 2014
    Managing director: Shravan Harikrishna Patel
    Trident Lifeline Limited was originally incorporated as Private Limited Company under the name Trident Lifeline Private Limited on January 09, 2014. Subsequently, Company converted into a Public Limited pursuant to Shareholders Resolution on June 02, 2022 and name of Company was changed to Trident Lifeline Limited on June 10, 2022. The Company is engaged in business of marketing ethical pharmaceutical products in domestic as well as international market. It is also engaged in distribution of pharmaceutical products through third party distribution network. Apart from these, the Company offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license. It operate in India as well as African, Latin American and East Indian Countries. Presently, it has presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanamar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, Venezuela.Presently, Company operates with one contract manufacturer, who maintained relationship with the regular supplier, having FDA and WHO approved plant to supply pharma formulations. These units manufacture tablets, capsules, dry powder, syrup under their own brands. Pharma business operations are supported by various contract manufacturers having facilities which are approved by FDA/WHO and other relevant authorities. The Company typically work on contract manufacturing basis or at times purchase order basis, depending upon customers requirement, with manufacturer of pharma products. The Company deal in Capsules, Tablets, Liquid Ointment, Gel, Ice Gel, Mouthwash, Paste, Solution, Suspension, Drypowders and Toothpaste. The product portfolio comprises of drugs like Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Nonsteriodal antiinflammatory drug (NSAIDS). Company made an Initial Public Offering (IPO) of 34,99,200 Equity Shares of face value Rs 10/ each by raising funds from public aggregating to Rs 35.3 Crore in September, 2022. The Company acquired 51% equity stake in TNS Pharma Private Limited, making it a subsidiary of the Company in 2023, TLL Herbal Limited became a subsidiary Company pursuant to acquisition of 51% equity shares w.e.f. August 10, 2023.

    As of 14 Jul, 2025, Trident Lifeline share price is ₹267. The stock opened at ₹266.5 and had closed at ₹269.2 the previous day. During today’s trading session, Trident Lifeline share price moved between ₹265.00 and ₹267.15, with an average price for the day of ₹266.07. Over the last 52 weeks, the stock has recorded a low of ₹222.00 and a high of ₹339.00. In terms of performance, Trident Lifeline share price has declined by 2% over the past six months and has declined by 15.14% over the last year.

    Read More
    View details of Market Depth

    Trident Lifeline Fundamental

    Market Cap (in crs)

    307.03

    Face Value

    10

    Turnover (in lacs)

    12.82

    Key Metrics

    Qtr Change %
    4.7
    Dividend yield 1yr %
    0

    Trident Lifeline Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Trident Lifeline Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    46.53 Cr
    11.83 Cr
    15.45 Cr
    13.15 Cr
    19.13 Cr
    Trident Lifeline Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022
    95.2 Cr
    46.71 Cr
    32.85 Cr
    22.37 Cr
    Trident Lifeline Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    3.53 Cr
    2.56 Cr
    2.81 Cr
    1.6 Cr
    1.62 Cr
    Trident Lifeline Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022
    10.49 Cr
    5.94 Cr
    6.02 Cr
    2.28 Cr

    Top Mutual Fund Invested in Trident Lifeline

    Promoter
    63%
    Foreign Institutions
    6.6%
    Domestic Institutions
    0.1%
    Public
    30.2%
    Promoter
    63%
    Foreign Institutions
    6.1%
    Public
    30.9%
    Promoter
    63%
    Foreign Institutions
    6.1%
    Public
    30.9%
    Promoter
    65.5%
    Foreign Institutions
    6%
    Public
    28.5%
    Promoter
    67.5%
    Foreign Institutions
    6%
    Public
    26.5%
    Promoter
    70%
    Foreign Institutions
    4.6%
    Public
    25.3%

    Trident Lifeline Technical Analysis

    Moving Averages Analysis
    267
    Current Price
    Bullish Moving Averages
    1
    Bearish Moving Averages
    15
    5Day EMA
    269.40
    10Day EMA
    271.60
    12Day EMA
    272.20
    20Day EMA
    274.00
    26Day EMA
    274.60
    50Day EMA
    274.30
    100Day EMA
    273.30
    200Day EMA
    265.20
    5Day SMA
    268.50
    10Day SMA
    273.20
    20Day SMA
    274.70
    30Day SMA
    277.70
    50Day SMA
    276.00
    100Day SMA
    268.60
    150Day SMA
    277.30
    200Day SMA
    284.00
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    2400 Rs
    4800 Rs
    Week Rs
    1800 Rs
    3000 Rs
    Month Rs
    null Rs
    null Rs
    266.38
    Pivot
    Resistance
    First Resistance
    267.77
    Second Resistance
    268.53
    Third Resistance
    269.92
    Support
    First Support
    265.62
    Second support
    264.23
    Third Support
    263.47
    Relative Strength Index
    45.19
    Money Flow Index
    75.10
    MACD
    -2.40
    MACD Signal
    -1.28
    Average True Range
    9.46
    Average Directional Index
    10.85
    Rate of Change (21)
    -3.64
    Rate of Change (125)
    -14.08
    Name
    Holding Percent
    Nav Capital Vcc - Nav Capital Emerging Star Fund
    6.01

    Trident Lifeline Latest News

    09 JUL 2025 | Wednesday

    Trident Lifeline Ltd - 543616 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    04 JUL 2025 | Friday

    Trident Lifeline Ltd - 543616 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    04 JUL 2025 | Friday

    Trident Lifeline Ltd - 543616 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    View More

    Trident Lifeline Share Price FAQs

    You can easily buy Trident Lifeline shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Trident Lifeline share price is ₹339 and ₹222 as of 14/7/2025.

    Please be aware that Trident Lifeline stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    67.17
    +1.73 (+2.64%)
    135.29
    +1.18 (+0.88%)
    684.40
    +9.90 (+1.47%)
    2,598.20
    +16.90 (+0.65%)
    159.64
    +0.64 (+0.40%)
    383.15
    +0.85 (+0.22%)
    159.00
    -1.44 (-0.90%)
    266.45
    -4.15 (-1.53%)
    408.95
    +1.65 (+0.41%)
    403.90
    +1.35 (+0.34%)
    Top Gainers
    4,454.00
    +202.30 (+4.76%)
    8,311.00
    +223.50 (+2.76%)
    1,727.50
    +44.90 (+2.67%)
    684.45
    +14.70 (+2.19%)
    7,360.50
    +140.50 (+1.95%)
    Top Losers
    1,566.40
    -53.40 (-3.30%)
    266.45
    -4.15 (-1.53%)
    1,824.80
    -26.50 (-1.43%)
    756.85
    -7.90 (-1.03%)
    159.00
    -1.44 (-0.90%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -